153 related articles for article (PubMed ID: 30602290)
1. The prognostic significance of macroscopic serosal change in subserosal invasion (stage T3) gastric cancer.
Zhao B; Mei D; Zhang J; Zou S; Lu H; Xu H; Huang B
Ann R Coll Surg Engl; 2019 Apr; 101(4):249-255. PubMed ID: 30602290
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of macroscopic serosal change on resectable advanced gastric cancer.
Yura M; Yoshikawa T; Wada T; Otsuki S; Hayashi T; Yamagata Y; Katai H; Nishida T
BMC Cancer; 2021 Sep; 21(1):1056. PubMed ID: 34563160
[TBL] [Abstract][Full Text] [Related]
4. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
Wang PL; Huang JY; Zhu Z; Gong BC; Huang HW; Duan SJ; Xu HM; Liu FN
Eur J Surg Oncol; 2018 May; 44(5):600-606. PubMed ID: 29454557
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of macroscopic intraoperative diagnosis of serosal invasion and risk of over- and underestimation in gastric carcinoma.
Jeong O; Ryu SY; Jeong MR; Sun JW; Park YK
World J Surg; 2011 Oct; 35(10):2252-8. PubMed ID: 21850605
[TBL] [Abstract][Full Text] [Related]
6. Clinical implication of serosal change in pathologic subserosa-limited gastric cancer.
Kim JM; Jung H; Lee JS; Lee HH; Song KY; Park CH; Jeon MH
World J Surg; 2012 Feb; 36(2):355-61. PubMed ID: 22146944
[TBL] [Abstract][Full Text] [Related]
7. Macroscopic intraoperative diagnosis of serosal invasion and clinical outcome of gastric cancer: risk of underestimation.
Ichiyoshi Y; Maehara Y; Tomisaki S; Oiwa H; Sakaguchi Y; Ohno S; Sugimachi K
J Surg Oncol; 1995 Aug; 59(4):255-60. PubMed ID: 7630174
[TBL] [Abstract][Full Text] [Related]
8. Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery.
Sun Z; Xu YY; Wang ZN; Zhu Z; Zhang H; Huang BJ; Xu Y; Chen JQ; Xu HM
Ann Surg Oncol; 2011 Apr; 18(4):1068-80. PubMed ID: 21293933
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of the width of subserosal invasion in gastric cancer invading the subserosal layer.
Soga K; Ichikawa D; Yasukawa S; Kubota T; Kikuchi S; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Yanagisawa A; Otsuji E
Surgery; 2010 Feb; 147(2):197-203. PubMed ID: 19758672
[TBL] [Abstract][Full Text] [Related]
10. Impact of Subclassification of Serosal Invasion on the Survival of Patients With T4a Gastric Cancer.
Nakamura K; Tajima K; Kanamori K; Yatabe K; Ogimi M; Higuchi T; Yamamoto M; Hara H; Kazuno A; Nabeshima K; Nomura E; Koyanagi K
In Vivo; 2022; 36(4):1923-1929. PubMed ID: 35738632
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive surgery for serosa-positive gastric cancer (pT4a) in patients with preoperative diagnosis of cancer without serosal invasion.
Son T; Hyung WJ; Lee JH; Kim YM; Noh SH
Surg Endosc; 2014 Mar; 28(3):866-74. PubMed ID: 24149848
[TBL] [Abstract][Full Text] [Related]
12. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
[TBL] [Abstract][Full Text] [Related]
13. Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer.
Togano S; Yashiro M; Miki Y; Yamamoto Y; Sera T; Kushitani Y; Sugimoto A; Kushiyama S; Nishimura S; Kuroda K; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Tanaka S; Ohira M
PLoS One; 2020; 15(1):e0225958. PubMed ID: 31940352
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in gastric cancer with serosal invasion--importance of the extent of cancer infiltration in the subserosal layer].
Habu H; Kando F; Saito N; Takeshita K; Sunagawa M; Endo M
Gan No Rinsho; 1989 May; 35(6):685-9. PubMed ID: 2724547
[TBL] [Abstract][Full Text] [Related]
15. Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer.
Abe S; Shiraishi M; Nagaoka S; Yoshimura H; Dhar DK; Nakamura T
Surgery; 1991 May; 109(5):582-8. PubMed ID: 2020903
[TBL] [Abstract][Full Text] [Related]
16. Width of serosal invasion and prognosis in advanced human gastric cancer with special reference to the mode of tumor invasion.
Baba H; Korenaga D; Haraguchi M; Okamura T; Saito A; Watanabe A; Sugimachi K
Cancer; 1989 Dec; 64(12):2482-6. PubMed ID: 2819657
[TBL] [Abstract][Full Text] [Related]
17. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
18. Is bursectomy necessary for patients with gastric cancer invading the serosa?
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Hasegawa S; Ishiwa N; Morinaga S; Noguchi Y; Yamamoto Y; Matsumoto A
Hepatogastroenterology; 2004; 51(59):1524-6. PubMed ID: 15362792
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative dissemination during gastrectomy for gastric cancer associated with serosal invasion.
Tokumitsu Y; Yoshino S; Iida M; Yoshimura K; Ueno T; Hazama S; Oka M
Surg Today; 2015 Jun; 45(6):746-51. PubMed ID: 25115929
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the peritoneal recurrence via the macroscopic diagnosis of the serosal invasion in patients with gastric cancer: Supplementary analysis of JCOG0110.
Terashima M; Sano T; Mizusawa J; Umemura K; Tokunaga M; Omori T; Cho H; Hasegawa Y; Akiyama Y; Tsujimoto H; Kawashima Y; Kawachi Y; Lee SW; Kano K; Hasegawa H; Boku N; Yoshikawa T; Sasako M
Eur J Surg Oncol; 2022 Aug; 48(8):1753-1759. PubMed ID: 35082047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
